Evolving Treatment Patterns for Hospitalized COVID-19 Patients in the United States in April 2020–July 2020

Xiaozhou Fan1 Medical Device Epidemiology and Real World Data Sciences, Johnson & Johnson, New Brunswick, NJ, USACorrespondence[email protected]

https://orcid.org/0000-0002-7992-3232 View further author information

Barbara H Johnson1 Medical Device Epidemiology and Real World Data Sciences, Johnson & Johnson, New Brunswick, NJ, USA

https://orcid.org/0000-0001-7973-8902 View further author information

Stephen S Johnston1 Medical Device Epidemiology and Real World Data Sciences, Johnson & Johnson, New Brunswick, NJ, USAView further author information

Nivesh Elangovanraaj2 Mu Sigma Inc, Bangalore, India

https://orcid.org/0000-0002-8740-8249 View further author information

Paul Coplan1 Medical Device Epidemiology and Real World Data Sciences, Johnson & Johnson, New Brunswick, NJ, USA

https://orcid.org/0000-0002-7078-7780 View further author information

Rahul Khanna1 Medical Device Epidemiology and Real World Data Sciences, Johnson & Johnson, New Brunswick, NJ, USA

https://orcid.org/0000-0002-2478-1724 View further author information

References

Ballinger GA. Using generalized estimating equations for longitudinal data analysis. Organ Res Methods. 2004;7(2):127–150. doi:10.1177/1094428104263672
Web of Science ®Google Scholar
Cortegiani A, Ippolito M, Ingoglia G, et al. Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19. J Crit Care. 2020;59:176–190. doi:10.1016/j.jcrc.2020.06.019
PubMed Web of Science ®Google Scholar
McCreary EK, Angus DC. Efficacy of Remdesivir in COVID-19. JAMA. 2020;324(11):1041–1042. doi:10.1001/jama.2020.16337
PubMed Web of Science ®Google Scholar
Horby P, Lim WS, Emberson J, et al. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv. 2020. doi:10.1101/2020.06.22.20137273
Google Scholar
Jeronimo CMP, Farias MEL, Val FFA, et al. Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, Phase IIb, Placebo-controlled trial. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa1177
Web of Science ®Google Scholar
Kollias A, Kyriakoulis KG, Dimakakos E, et al. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020;189(5):846–847. doi:10.1111/bjh.16727
PubMed Web of Science ®Google Scholar
Saheb Sharif-Askari N, Saheb Sharif-Askari F, Al Heialy S, et al. Cardiovascular medications and regulation of COVID-19 receptors expression. Int J Cardiol Hypertens. 2020;6:100034. doi:10.1016/j.ijchy.2020.100034
PubMedGoogle Scholar

Evolving Treatment Patterns for Hospitalized COVID-19 Patients in the United States in April 2020–July 2020

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Evolving Treatment Patterns for Hospitalized COVID-19 Patients in the United States in April 2020–July 2020

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date